Eagle Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $322k | 62k | 5.23 |
| 2023-09-30 | $996k | 63k | 15.77 |
| 2023-06-30 | $2.3M | 118k | 19.44 |
| 2023-03-31 | $3.4M | 122k | 28.07 |
| 2022-12-31 | $3.3M | 111k | 29.22 |
| 2022-06-30 | $9.1M | 205k | 44.41 |
| 2022-03-31 | $12M | 239k | 49.49 |
| 2021-12-31 | $12M | 244k | 50.94 |
| 2021-03-31 | $2.9M | 69k | 41.74 |
| 2020-12-31 | $3.5M | 76k | 46.55 |
| 2020-09-30 | $2.6M | 63k | 41.82 |
| 2020-06-30 | $3.1M | 65k | 47.89 |
| 2020-03-31 | $3.1M | 68k | 45.85 |
| 2019-12-31 | $4.6M | 76k | 59.97 |
| 2019-09-30 | $4.5M | 80k | 56.53 |
| 2019-06-30 | $5.4M | 99k | 54.96 |
| 2019-03-31 | $5.3M | 105k | 50.48 |
| 2018-12-31 | $2.4M | 59k | 40.28 |
| 2018-09-30 | $4.4M | 64k | 69.33 |
| 2018-06-30 | $2.6M | 34k | 75.69 |
| 2018-03-31 | $124k | 2.4k | 52.56 |
| 2017-12-31 | $127k | 2.4k | 53.60 |
| 2016-06-30 | $5.0k | 124 | 40.32 |
| 2016-03-31 | $4.0k | 89 | 44.94 |
| 2015-12-31 | $1.0k | 10 | 100.00 |
| 2015-03-31 | $278k | 6.6k | 41.93 |
| 2014-03-31 | $2.3M | 178k | 12.74 |